Direxion Daily S&P Biotech Bull 3X Shares
Limited financial coverage for LABU.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. It invests in public equity markets of the United States.
- IPO
- 2015
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on LABU
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $918.11M
- Div Yield
- 0.53%
- 52W High
- $341.93
- 52W Low
- $131.75
- 50D MA
- $237.41
- 200D MA
- $219.69
- Beta
- 2.86
- RSI (14)
- 36
- Avg Volume
- 379.64K
No earnings-call transcripts are available for LABU yet.
- Free Float
- —
- Shares Outstanding
- 5.34M
- Float Shares
- —
of shares held by institutions
41 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Goldman Sachs Group Inc | 100.24K | ▲ 41.61K |
| Jane Street Group, LLC | 29.93K | ▲ 28.01K |
| Hrt Financial LP | 23.06K | ▲ 23.06K |
| Susquehanna International Group, Llp | 21.95K | ▼ 27.53K |
| Gts Securities LLC | 17.56K | ▲ 101 |
| Two Sigma Securities, LLC | 6.06K | ▲ 944 |
| Ethos Financial Group, LLC | 5.75K | ▲ 2.44K |
| Ubs Group AG | 5.46K | ▲ 4.00K |
| Bank Of New York Mellon Corp | 5.25K | 0 |
| Mcguire Investment Group, LLC | 5.14K | ▼ 80 |
| Allworth Financial LP | 4.22K | 0 |
| Cibc Private Wealth Group LLC | 3.75K | 0 |
Our LABU coverage
Recent articles, reports, and earnings notes.
No research on LABU yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LABU report →Why $55 Million Flowed Into a Triple-Leveraged Biotech ETF Worth Less Than $600 Million
247wallst.com · Oct 20
Biotech's Rebound Reality: Surging M&A Deals Meet Deep Retail Skepticism
etftrends.com · Oct 12
LABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited Breakout
247wallst.com · Apr 27
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now
247wallst.com · Apr 23
34,270 Shares in Direxion Daily S&P Biotech Bull 3x Shares $LABU Purchased by JPMorgan Chase & Co.
defenseworld.net · Apr 5
Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Shares Gap Down – Here’s Why
defenseworld.net · Feb 22
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026
247wallst.com · Jan 16
Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Hits New 1-Year High – What’s Next?
defenseworld.net · Jan 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.